Key points are not available for this paper at this time.
Despite advances in diabetes technologies, medications, and dissemination of more aggressive glycemic targets, many current YYA are less likely to achieve desired glycemic control relative to earlier cohorts.
Malik et al. (Fri,) studied this question.